SAFETY AND IMMUNOGENICITY OF HEPATITIS B VACCINE BUTANG IN ADULTS
Ano: 1999 | Volume: 41 | Número: 3
Autores: L. M. Ioshimoto, M. L. Rissato, V. S. J. Bonilha, C. Miyaki, I. Raw, N. Granovski Autor Correspondente: Luzia M IOSHIMOTO | revimtsp@edu.usp.br
Palavras-chave: hepatitis b vaccine, clinical trials
Resumos Cadastrados
Resumo Inglês:
Recombinant yeast-derived hepatitis B vaccine manufactured by Instituto Butantan was administered in
